Thank you Brandon Trujillo, OMS IV for the capstone to the series about treatment of depression. Thank you Natalie Pratt, OMS IV and Cam Mecham, OMS IV, for chipping in to provide additional expertise.

This podcast reviews some of the previous information from the podcasts describing medications, but focuses on the practical implementation of those strategies. It may have more benefit for the Standardized Patient than for learning principles needed for shelf and board exams. Even though the focus is not on those exams, there is repetition of many concepts that do show up on those exams.

Thank you Brandon Trujillo, OMS IV, for developing this podcast as another step in better understanding how to tackle difficult to treat depression. Thank you Natalie Pratt OM,S IV and Cam Mecham OMS IV for joining in!

This is a modest yield podcast for principles tested in exams and more helpful for understanding the options used to treat depression when it doesn't respond to first line treatments.

Thank you Brandon Trujillo, OMS IV for continuation of the podcasts focused on treatment of depression in a systematic fashion. Thank you Natalie Pratt, OMS IV; Cam Mecham, OMS IV; Angelo Garcia, OMS III and Rhett Dotson, OMS III for participating in the presentation.

This presentation covers high yield principles that are tested but the area of coverage is narrow.

Thank you Brandon Trujillo, OMS IV for continuing a thoughtful series on treatment of depression and key principles of algorithmic treatment and key aspects of antidepressant use. This is a modest yield podcast as there will be questions regarding principles in this podcast that are likely to show up in tests. Thank you Jason Hemingway, OMS IV and Natalie Pratt, OMS IV for participating in the discussion.

Thank you Brandon Trujillo, OMS IV for developing this topic. Thank you Natalie Pratt, OMS IV and Jamon Hemingway OMS IV for participating.

This is a high yield discussion about principles that are tested on board and shelf exams.

Thank you Nuriya Gadiwalla, OMS III for developing this important and fascinating topic. Thank you Jamon Hemingway, OMS IV and Ray Kwong OMS III for participating. 

This presentation has limited benefit for shelf preparation, but seemed to provide a great deal of education to students (and me) to help provide better care for my patients.

The current WPATH guidelines mentioned in this presentation can be found here: https://www.wpath.org/publications/soc

Thank you Jamon Hemingway, OMS IV for developing the concept of focusing on learning around a neurotransmitters and neuroanatomy.  Also participating were Nuriya Gadiwalla, OMS III; Brandon Trujillo, OMS IV and Natalie Pratt, OMS IV.

This podcast has moderate yield regarding high value topics about dopamine and how this neurotransmitter and the location of this neurotransmitter matter for psychiatric illness and for side effects of medications.

Thank you Brandon Trujillo, OMS IV; Natalie Pratt, OMS IV and Nuriya Gadiwalla, OMS III for the discussion. This was an unplanned presentation that involved discussions about principles that seem to be commonly used in examination settings. This seems to be high yield.

Thank you to Brandon Trujillo, OMS IV who helped to introduce this topic. Thank you also Nuriya Gadiwalla OMS III and Natalie Pratt, OMS IV for participating.

Note that this has limited yield for students preparing for their shelf exam. It does set the stage for exploration of algorithmic treatment of depression in a series of podcasts that are anticipated to follow.

Thank you Ray Kwong, OMS III for developing the topic and finding the great articles! Thank you Brandon Trujillo OMS IV and Natalie Pratt, OMS IV for participating.

This podcast is of minimal shelf exam benefit. It does address the key issues of recognition of Tourette's Syndrome and treatment that may show up on practice tests and shelf exams.

This article by Kevin Black describes the ongoing research into tics and a great summary of current information about the condition. It is freely available through Pubmed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316401/

Aripiprazole and Haloperidol have FDA indications for treatment of Tourette's, but not Risperidone.

The correct pronunciation of Premonitory (very different than how we were saying it)! https://www.youtube.com/watch?v=2kaGcByXeDE

ed 8/25/2020 to include correct pronunciation of "Premonitory"